NCT03237273 HEAD-US SCORING SYSTEM: Assessment of the Real-world Impact of Ultrasound Status UNKNOWN Phase NA
NCT03236493 Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03236051 Multimodal Analgesia in Laparoscopic Radical Gastrectomy With Gastric Cancer: a Multi-center Study Status UNKNOWN Phase NA
NCT03235479 Safety and Efficacy Study in Adult Subjects With Acute Migraines Status COMPLETED Phase PHASE3
NCT03233529 Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03232905 Safety and Pharmacokinetic Study of PF-06651600 in Japanese Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03230383 A Study To Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult Subjects Status COMPLETED Phase PHASE1
NCT03220230 Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients. Status COMPLETED Phase N/A
NCT03220191 Proton Pump Inhibitor (PPI, Rabeprazole) Effect On Tablet Formulation Of Palbociclib Status COMPLETED Phase PHASE1
NCT03220178 Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy Status TERMINATED Phase PHASE4
NCT03217604 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03210961 A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT03205267 Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients Status UNKNOWN Phase PHASE2
NCT03192215 AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke Status TERMINATED Phase PHASE3
NCT03190577 Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology Status COMPLETED Phase NA
NCT03189745 A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered). Status COMPLETED Phase PHASE3
NCT03185481 Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations Status TERMINATED Phase PHASE2
NCT03184168 Single-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male Volunteers Status COMPLETED Phase PHASE1